###begin article-title 0
###xml 56 61 56 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5 </italic>
###xml 50 55 <span type="species:ncbi:9606">human</span>
Sp1 and KLF15 regulate basal transcription of the human LRP5 gene
###end article-title 0
###begin title 1
Background
###end title 1
###begin p 2
###xml 224 229 224 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5 </italic>
###xml 218 223 <span type="species:ncbi:9606">human</span>
LRP5, a member of the low density lipoprotein receptor superfamily, regulates diverse developmental processes in embryogenesis and maintains physiological homeostasis in adult organisms. However, how the expression of human LRP5 gene is regulated remains unclear.
###end p 2
###begin title 3
Results
###end title 3
###begin p 4
###xml 65 70 65 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5 </italic>
###xml 319 324 319 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5 </italic>
###xml 466 477 466 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila </italic>
###xml 537 542 537 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5 </italic>
###xml 59 64 <span type="species:ncbi:9606">human</span>
###xml 313 318 <span type="species:ncbi:9606">human</span>
In order to characterize the transcriptional regulation of human LRP5 gene, we cloned the 5' flanking region and evaluated its transcriptional activity in a luciferase reporter system. We demonstrated that both KLF15 and Sp1 binding sites between -72 bp and -53 bp contribute to the transcriptional activation of human LRP5 promoter. Chromatin immunoprecipitation assay demonstrated that the ubiquitous transcription factors KLF15 and Sp1 bind to this region. Using Drosophila SL2 cells, we showed that KLF15 and Sp1 trans-activated the LRP5 promoter in a manner dependent on the presence of Sp1-binding and KLF15-binding motifs.
###end p 4
###begin title 5
Conclusions
###end title 5
###begin p 6
###xml 75 80 75 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5 </italic>
###xml 180 185 180 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5 </italic>
###xml 69 74 <span type="species:ncbi:9606">human</span>
###xml 174 179 <span type="species:ncbi:9606">human</span>
Both KLF15 and Sp1 binding sites contribute to the basal activity of human LRP5 promoter. This study provides the first insight into the mechanisms by which transcription of human LRP5 gene is regulated.
###end p 6
###begin title 7
Background
###end title 7
###begin p 8
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5 </italic>
###xml 303 304 303 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 333 344 333 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila </italic>
###xml 369 370 369 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 432 433 432 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 729 730 729 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 915 916 915 916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 1028 1029 1028 1029 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 1030 1031 1030 1031 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 26 31 <span type="species:ncbi:9606">human</span>
###xml 274 279 <span type="species:ncbi:9606">human</span>
###xml 284 289 <span type="species:ncbi:10090">mouse</span>
The LRP5 gene, located on human chromosome 11q13, contains 23 exons encoding a 1615 amino acid single-pass transmembrane receptor that belongs to the low density lipoprotein (LDL) receptor superfamily. LRP5 is highly conserved between species. There is 95% identity between human and mouse LRP5 protein[1], and 40% identity with the Drosophila orthologous gene, Arrow [2]. Additionally, LRP5 bears 71% amino acid identity with LRP6[3]. LRP5 contains an extracellular domain, a membrane-spanning domain, and an intracellular domain. The extracellular domain, located at the N-terminus, consists of four EGF-receptor-like cysteine-rich repeats with associated YWTD spacer domains and three LDL receptor-like ligand binding domains[1]. LRP5 is expressed in multiple adult and embryonic tissues, including bone, macrophages, fat, brain, heart, liver, skin and pancreas, with strongest expression occurring in the liver[1]. In bone, it is expressed by osteoblasts of the endosteal and trabecular bone surfaces but not by osteoclasts[4,5].
###end p 8
###begin p 9
###xml 163 164 163 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 165 166 165 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 167 168 167 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 207 212 207 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5 </italic>
###xml 451 452 451 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 560 561 560 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 562 563 562 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 670 674 670 674 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lrp5</italic>
###xml 690 691 690 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 733 738 733 738 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5 </italic>
###xml 872 873 872 873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 958 963 958 963 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5 </italic>
###xml 1037 1039 1037 1039 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 1040 1042 1040 1042 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 201 206 <span type="species:ncbi:9606">human</span>
###xml 602 607 <span type="species:ncbi:9606">human</span>
###xml 685 689 <span type="species:ncbi:10090">mice</span>
###xml 698 713 <span type="species:ncbi:10090">transgenic mice</span>
Shortly after the discovery of LRP5, multiple lines of evidence indicate that the LRP5 plays an important role in bone formation through the Wnt signaling pathway[4,6,7]. Loss-of-function mutations in human LRP5 gene cause the osteoporosis-pseudoglioma syndrome (OPPG), an autosomal-recessive condition of juvenile onset characterized by blindness due to aberrant vitreo-retinal vascular growth and osteoporosis resulting in fractures and deformation[4]. Gain-of-function mutation (G171V) in the same gene, on the other hand, resulted in high bone mass (HBM) [6-8]. Consistent with the observations in human, bone formation and osteoblast proliferation are decreased in Lrp5-deficient mice[5], and transgenic mice that expressed the LRP5 G171V mutation in osteoblasts exhibited enhanced osteoblastic activity, reduced osteoblast apoptosis, and a high bone mass phenotype [9]. Furthermore, independent epidemiological studies have linked sequence variants in LRP5 gene with differences in bone mineral density (BMD) and/or fracture risk [10-13].
###end p 9
###begin p 10
###xml 177 182 177 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5 </italic>
###xml 197 202 197 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP6 </italic>
###xml 307 309 307 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 310 312 310 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 330 332 330 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 361 363 361 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 509 511 509 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 512 514 512 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 1043 1045 1043 1045 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 46 54 <span type="species:ncbi:9606">patients</span>
Consistent with the observation with the OPPG patients, other diseases associated with abnormal angiogenesis or vascularization of the eye are also associated with mutations in LRP5 or its paralog LRP6 as well as proteins that interact with the two receptors, including familial exudative vitroretinopathy [14-16], Norrie disease[17], and macular degeneration [18]. In addition to its essential role in bone accrual and eye development, the LRP5 is also required for normal cholesterol and glucose metabolism[19,20]. Thus, LRP5 is a widely expressed receptor and is critical for normal development. It regulates diverse developmental processes in embryogenesis and maintains physiological homeostasis in adult organisms. Interestingly, the most studied functions of LRP5 are related to its roles as a co-receptor for the frizzled family of Wnt receptors. Yadav et al recently demonstrated the existence of a novel regulatory pathway whereby gut-derived 5-hydroxytryptamine indirectly mediates the function of LRP5 in skeletal differentiation [21].
###end p 10
###begin p 11
###xml 98 103 98 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5 </italic>
###xml 160 165 160 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5 </italic>
###xml 544 549 544 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5 </italic>
###xml 538 543 <span type="species:ncbi:9606">human</span>
Despite its important roles in several developmental processes, the transcriptional regulation of LRP5 remains unclear. Information regarding the regulation of LRP5 gene expression may help us to understand its function and find potential new anabolic targets for conditions such as osteoporosis. To this end, we cloned the 5' flanking region and evaluated its transcriptional activity in a luciferase reporter system. We demonstrate that both Kruppel-like factor 15(KLF15) and specificity protein 1(Sp1) binding motifs are essential for human LRP5 promoter activity.
###end p 11
###begin title 12
Results
###end title 12
###begin title 13
###xml 71 76 71 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5 </italic>
###xml 65 70 <span type="species:ncbi:9606">human</span>
Identification of putative transcription factor binding sites in human LRP5 promoter region
###end title 13
###begin p 14
###xml 28 33 28 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5 </italic>
###xml 130 135 130 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5 </italic>
###xml 175 180 175 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5 </italic>
###xml 389 391 389 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1A</xref>
###xml 482 487 482 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5 </italic>
###xml 867 869 867 869 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1B</xref>
###xml 22 27 <span type="species:ncbi:9606">human</span>
###xml 124 129 <span type="species:ncbi:9606">human</span>
###xml 169 174 <span type="species:ncbi:9606">human</span>
###xml 476 481 <span type="species:ncbi:9606">human</span>
Before characterizing human LRP5 promoter, primer extension was performed to identify the transcription start site (TSS) of human LRP5 gene. We observed that the TSS of human LRP5 gene was located 40 nucleotides upstream of the 5' end of the published cDNA sequence (GenBank accession No: ), corresponding to a T residue at position 114 upstream of the ATG translation start site (Figure. 1A). In order to identify putative transcription factor binding sites, we analyzed the human LRP5 5'-flanking sequence from -2381 to +125 (relative to transcription start site) using the programs MatInspector  and AliBaba 2.1 . No canonical TATA box or CAAT-like sequences were evident. However, several potential transcription factor binding motifs were identified in the promoter region close to transcription start site, including Sp1, KLF15, MZF, MAZ, CDE and ZBPF (Figure. 1B).
###end p 14
###begin p 15
###xml 33 38 33 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5 </italic>
###xml 104 109 104 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5 </italic>
###xml 0 117 0 117 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Identification of the TSS of the <italic>LRP5 </italic>gene and the putative transcription factor binding sites in human <italic>LRP5 </italic>promoter</bold>
###xml 302 306 302 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5</italic>
###xml 98 103 <span type="species:ncbi:9606">human</span>
###xml 296 301 <span type="species:ncbi:9606">human</span>
Identification of the TSS of the LRP5 gene and the putative transcription factor binding sites in human LRP5 promoter. (A) The transcription start site (TSS) was determined by primer extension, and the extended product is indicated by the arrow. (B) Nucleotide sequence surrounding the 5' end of human LRP5. The numbering of the sequence is relative to TSS. Distinct DNA binding sites for transcription factors are indicated (underlined). The numbers above the sequence referred to the 5' position of serial deletion constructs. The primers used in ChIP assay are indicated in italic and bold.
###end p 15
###begin title 16
###xml 30 35 30 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5 </italic>
###xml 24 29 <span type="species:ncbi:9606">human</span>
The minimal promoter of human LRP5 gene is located within the region -72/-53 relative to the transcription start site
###end title 16
###begin p 17
###xml 67 72 67 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5 </italic>
###xml 518 520 518 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2A</xref>
###xml 894 899 894 899 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5 </italic>
###xml 888 893 <span type="species:ncbi:9606">human</span>
To determine the minimal region required for basal activity of the LRP5 promoter, a series of deletion constructs were generated, designated as pWT-2381, pWT-1901, pWT-1594, pWT-1442, pWT-1309, pWT-1167, pWT-1085, pWT-953 and pWT-359 based on their variable 5' end. U2OS and HEK293 cells, representing cells of osteoblastic and non-osteoblastic origin, respectively, were used to evaluate the promoter activities and to determine whether there exist regulatory elements that are specific to osteoblastic cells. Figure 2A summarizes the results of these transfection analyses. Maximal promoter activity was observed with the construct pWT-359 in both U2OS and HEK293 cells. When the sequence length increased up to -2381, a 50% reduction in luciferase activities was observed, suggesting the presence of negative regulatory elements between -2381 and -359. These results indicate that the human LRP5 proximal promoter elements are located downstream -359 and that there are essential positive control elements within the sequence from -359 to +125. Similar trends were observed in U2OS cells and HEK293 cells, suggesting that the regulatory sequences within the region examined were not cell-specific.
###end p 17
###begin p 18
###xml 87 92 87 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5 </italic>
###xml 0 100 0 100 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A sequence located between -72 and -53 confers basal transcriptional activity of human <italic>LRP5 </italic>promoter</bold>
###xml 81 86 <span type="species:ncbi:9606">human</span>
A sequence located between -72 and -53 confers basal transcriptional activity of human LRP5 promoter. (A and B) Serial 5' deletion constructs were transfected into U2OS and HEK293 cells, and the relative luciferase activity was determined. The activity of pGL3-basic construct in A or that of pWT-359 construct in B was arbitrarily set to 100%, and the relative luciferase activity of the other constructs was calculated accordingly. Each bar represents the value of mean +/- SEM.
###end p 18
###begin p 19
###xml 53 58 53 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5 </italic>
###xml 318 320 318 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2B</xref>
###xml 649 654 649 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5 </italic>
###xml 790 795 790 795 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5 </italic>
###xml 784 789 <span type="species:ncbi:9606">human</span>
To further define the sequence required for proximal LRP5 promoter activity, a new series of deletion constructs were then generated by PCR, designed as pWT-219, pWT-167, pWT-72, pWT-53 and pWT-40. The relative luciferase activities were compared to that of pWT-359 construct which was set as 100%. As shown in figure 2B, no significant reduction of the reporter activity was detected in the HEK293 and U2OS cell lines when deletions were made between -359 and -72. However, deletion from nucleotides -72 to -53 resulted in 80% reduction in the promoter activity. These deletion experiments indicate that the essential positive control elements for LRP5 promoter activity are located between -72 and -53. Therefore, we decided to firstly focus our interest on the minimal promoter of human LRP5 gene.
###end p 19
###begin title 20
###xml 72 77 72 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5 </italic>
###xml 66 71 <span type="species:ncbi:9606">human</span>
The KLF15 and Sp1 binding sites between -72 and -53 contribute to human LRP5 promoter activity
###end title 20
###begin p 21
###xml 456 458 456 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3A</xref>
###xml 515 518 515 518 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TTT</bold>
###xml 578 580 578 580 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TT</bold>
###xml 801 803 801 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3B</xref>
###xml 1287 1292 1287 1292 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5 </italic>
###xml 1343 1348 1343 1348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5 </italic>
###xml 1281 1286 <span type="species:ncbi:9606">human</span>
###xml 1337 1342 <span type="species:ncbi:9606">human</span>
The region between -72 and -53 is a GC-rich region, containing two overlapped transcription factor binding sites, one for KLF15 and the other for Sp1. To determine the contribution of the Sp1 and/or KLF15 sites to the promoter activity, point mutations were introduced into construct pWT-72 by PCR-based mutagenesis to generate either single or double mutant reporter plasmids which were designated as pMT1-72, pMT2-72, and pMT12-72, respectively (Figure. 3A). In pMT1-72, the KLF15 motif GCGGGGGG was mutated to GCTTTGGG, and in pMT2-72 the Sp1 motif GGGCGGA was mutated to GGGTTGA. The double mutant construct pMT12-72 contained mutations in both motifs. The luciferase activities driven by the native (pWT-72) and mutated constructs were measured in HEK293 and U2OS cells. As illustrated in figure 3B, relative to pWT-72, pMT1-72 and pMT2-72 showed 22-25% and 53-55% reduction in promoter activity, respectively, confirming the positive regulatory role of the KLF15 site and the Sp1 site. The luciferase activity driven by double mutant (pMT12-72) was reduced to 11% in HEK293 and 20% in U2OS cells, the values as observed in the construct that lacks both KLF15 and Sp1 binding sites (pWT-53). These results indicate that both KLF15 and Sp1 binding sites between -72 and -53 of human LRP5 promoter contribute to the basal activity of human LRP5 transcription.
###end p 21
###begin p 22
###xml 114 119 114 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5 </italic>
###xml 0 127 0 127 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KLF15 and Sp1 binding sites located between -72 and -53 contribute to the basal transcriptional activity of human <italic>LRP5 </italic>promoter</bold>
###xml 595 600 595 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5 </italic>
###xml 1139 1144 1139 1144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5 </italic>
###xml 1197 1205 1197 1205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HSD17B5 </italic>
###xml 1290 1295 1290 1295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5 </italic>
###xml 1354 1359 1354 1359 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5 </italic>
###xml 108 113 <span type="species:ncbi:9606">human</span>
###xml 1133 1138 <span type="species:ncbi:9606">human</span>
###xml 1191 1196 <span type="species:ncbi:9606">human</span>
KLF15 and Sp1 binding sites located between -72 and -53 contribute to the basal transcriptional activity of human LRP5 promoter. (A) Schematic representation of the KLF15 and Sp1 elements. Point mutations (underlined) were introduced to change the binding sites. (B) Constructs with native (pWT-72) or mutant KLF15 and/or Sp1 sites were transfected into HEK293 and U2OS cells, and the luciferase activity was determined. The luciferase activity of pWT-72 was arbitrarily set to 100%, and the activities of other constructs were calculated accordingly. (C and D) Sp1 and KLF15 transactivated the LRP5 promoter only if Sp1 and KLF15 binding sites were present. SL2 cells were cotransfected with either wild type construct (pWT-72) or mutated constructs (pMT1-72 or pMT2-72) along with the Sp1 (3C) or KLF15 (3D) expression constructs, and the relative luciferase activity was determined. The luciferase activity cotransfected with control vector (empty vector, EV) was set to 100%, and the relative activity under KLF15 or Sp1 stimulation was calculated accordingly. (E) Chromatin immunoprecipitation assay of KLF15 and Sp1 binding to human LRP5 promoter. The bindings of KLF15 and Sp1 to the human HSD17B5 promoter were used as a positive control (upper panel). The bindings of KLF15 to the LRP5 promoter (lower right panel) and the binding of Sp1 to the LRP5 promoter (lower left panel) were determined by ChIP using anti-KLF15 and anti-Sp1 antibodies, respectively. Anti-IgG antibodies were used as a negative control. The associated chromatin DNA fragments were amplified with the primer pairs flanking the Sp1 and KLF15 binding sites. Chromatin DNA input as described in the material and methods was subjected to the same PCR amplification.
###end p 22
###begin title 23
###xml 26 31 26 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5 </italic>
###xml 20 25 <span type="species:ncbi:9606">human</span>
Trans-activation of human LRP5 promoter by KLF15 and Sp1
###end title 23
###begin p 24
###xml 61 66 61 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5 </italic>
###xml 85 96 85 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila </italic>
###xml 362 364 362 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3C</xref>
###xml 369 371 369 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3D</xref>
###xml 398 403 398 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5 </italic>
###xml 576 578 576 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3C</xref>
###xml 601 603 601 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3D</xref>
###xml 645 650 645 650 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5 </italic>
###xml 738 743 738 743 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5 </italic>
To determine whether KLF15 and Sp1 functionally modulate the LRP5 promoter activity, Drosophila SL2 cells, which are deficient in Sp1 and KLF15, were utilized. SL2 cells were cotransfected with either the wild type pWT-72 construct or the constructs with mutated Sp1 and/or KLF15 binding sites along with the KLF15 or Sp1 expression plasmids. As shown in figure 3C and 3D, Sp1 and KLF15 stimulated LRP5 promoter activity of the wild type construct. However, the mutant constructs were not activated by co-transfection with corresponding expression constructs, pPacSp1 (Figure 3C) or pPacKLF15 (Figure 3D), indicating that transactivation of the LRP5 by Sp1 and KLF15 depends on the presence of Sp1-binding and KLF15-binding motifs in the LRP5 promoter.
###end p 24
###begin title 25
###xml 42 47 42 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5 </italic>
###xml 36 41 <span type="species:ncbi:9606">human</span>
In vivo binding of Sp1 and KLF15 to human LRP5 promoter
###end title 25
###begin p 26
###xml 391 393 391 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1B</xref>
###xml 475 483 475 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HSD17B5 </italic>
###xml 572 574 572 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 596 598 596 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3E</xref>
###xml 688 696 688 696 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HSD17B5 </italic>
###xml 709 714 709 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5 </italic>
###xml 773 778 773 778 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5 </italic>
###xml 767 772 <span type="species:ncbi:9606">human</span>
To verify in vivo promoter binding by transcription factors KLF15 and Sp1, chromatin immunoprecipitation (ChIP) was performed on HEK293 cells. The sonicated nuclear extract was subjected to immunoprecipitation with anti-KLF15 and anti-Sp1 antibodies, and the associated chromatin DNA fragments were amplified with the primer pairs flanking the KLF15 and Sp1 binding sites as shown in figure 1B. As a negative control, a reaction was included with antibodies against IgG. The HSD17B5 promoter which contains both Sp1 and KLF15 binding sites was used as a positive control [22]. As shown in figure 3E, Anti-KLF15 and anit-Sp1 antibodies, but not IgG antibodies, could immunoprecipitate the HSD17B5 promoter and LRP5 promoter in HEK293 cells. These results confirm that human LRP5 promoter is indeed bound by Sp1 and KLF15 transcription factors in vivo.
###end p 26
###begin title 27
Discussion
###end title 27
###begin p 28
###xml 66 71 66 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5 </italic>
###xml 254 259 254 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5 </italic>
###xml 571 576 571 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5 </italic>
###xml 605 616 605 616 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila </italic>
###xml 733 738 733 738 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5 </italic>
###xml 865 870 865 870 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5 </italic>
###xml 60 65 <span type="species:ncbi:9606">human</span>
###xml 248 253 <span type="species:ncbi:9606">human</span>
In the present study, we have for the first time cloned the human LRP5 promoter and analyzed its transcriptional regulation. We demonstrated that both KLF15 and Sp1 binding sites located between -72 and -53 contribute to basal promoter activity of human LRP5 gene. There are several lines of evidences. First, by generating a series of 5' deletions, we show that the core promoter is located between nucleotides -72 and -53 relative to transcription start site. Second, changing the KLF15 and Sp1 motifs within this region by introducing point mutations strongly reduced LRP5 promoter activity. Third, in Drosophila SL2 cells that lack endogenous Sp1 and KLF15, we show that expression of KLF15 and Sp1 is able to trans-activate the LRP5 promoter that contains Sp1-binding and KLF15-binding motifs. Finally, ChIP assay confirmed the binding of KLF15 and Sp1 to the LRP5 promoter in vivo.
###end p 28
###begin p 29
###xml 192 194 192 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 195 197 195 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 406 408 406 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 409 411 409 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 600 602 600 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 660 664 660 664 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rho </italic>
###xml 668 673 668 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRBP </italic>
###xml 684 686 684 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 712 719 712 719 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CLC-K1 </italic>
###xml 723 730 723 730 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CLC-K2 </italic>
###xml 741 743 741 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 764 770 764 770 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLUT4 </italic>
###xml 779 781 779 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 787 794 787 794 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AceCs2 </italic>
###xml 803 805 803 805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 1052 1057 1052 1057 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5 </italic>
###xml 1046 1051 <span type="species:ncbi:9606">human</span>
Kruppel-like factors (KLFs), a subclass of the zinc-finger family of transcriptional regulators, are critical regulators of growth and differentiation in a broad range of mammalian cell types[23,24]. Members of this gene family have been characterized as regulators of both tissue-specific and ubiquitous genes and can function as transcriptional activators and/or repressors depending on promoter context[24,25]. KLF15 is expressed in multiple tissues, including liver, white and brown adipose tissues, kidney, heart, and skeletal muscle, with strongest expression occurring in the liver and kidney[26]. KLF15 appears to be bi-functional, as it represses the Rho and IRBP promoters [27] and the kidney-specific CLC-K1 and CLC-K2 promoters [28], but activates the GLUT4 promoter[26] and AceCs2 promoter[29]. In this study, mutation of the KLF15 binding motif lead to a reduction of the promoter activity in HEK293 and U2OS cells, indicating that this motif located between -72 and -53 functions as a positive regulatory element and activates the human LRP5 promoter.
###end p 29
###begin p 30
###xml 539 541 539 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 542 544 542 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 647 652 647 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5 </italic>
###xml 790 795 790 795 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5 </italic>
###xml 942 947 942 947 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5 </italic>
###xml 641 646 <span type="species:ncbi:9606">human</span>
The zinc-finger protein Sp1, which belongs to Sp family, was identified as the major protein forming complexes with oligonucleotides containing Sp1 and KLF15 binding motifs. The Sp family has 9 members containing three conserved zinc finger DNA binding domains, designated Sp1 to Sp9. Among them, Sp1, Sp3 and Sp4 are closely related containing two major glutamine-rich transactivation domains that are essential for transcription activation. They bind GC motifs to regulate the expression of housekeeping, tissue-specific and viral genes[30,31]. In the present study, we identified a functional Sp1 binding site within the core promoter of human LRP5 gene. Mutation of the Sp1 site decreased the promoter activity by 53% in U2OS cells and 55% in HEK293 cells. Expression of Sp1 stimulated LRP5 promoter activity in a Sp1-binding site dependent manner. Therefore, Sp1 binding site located between -72 and -53 contributes to activation of the LRP5 promoter.
###end p 30
###begin p 31
###xml 57 63 57 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLUT4 </italic>
###xml 95 97 95 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 194 201 194 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AceCS2 </italic>
###xml 210 212 210 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 224 229 224 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5 </italic>
###xml 218 223 <span type="species:ncbi:9606">human</span>
KLF15 can directly interact with MEF2, and activates the GLUT4 promoter in a synergetic manner[26]. Yamamoto et al demonstrated that KLF15 in combination with Sp1, synergistically activates the AceCS2 promoter[29]. In human LRP5 promoter, KLF15 and Sp1 motifs overlap. Simultaneously mutating KLF15 and Sp1 binding elements decreased the promoter activity more dramatically. This activation may be mediated by a synergetic interaction between the KLF15 and Sp1 factors resulting in a combined effect on the promoter activity.
###end p 31
###begin title 32
Conclusions
###end title 32
###begin p 33
###xml 216 221 216 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5 </italic>
###xml 261 266 261 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5 </italic>
###xml 384 389 384 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5 </italic>
###xml 210 215 <span type="species:ncbi:9606">human</span>
###xml 255 260 <span type="species:ncbi:9606">human</span>
###xml 378 383 <span type="species:ncbi:9606">human</span>
Based on these data, we conclude that both KLF15 and Sp1 binding sites located between positions -72 to -53 relative to the transcription start site play critical roles in regulating the basal transcription of human LRP5 gene. The characterization of the human LRP5 basal promoter represents a starting point to further unravel the underlying molecular mechanisms that regulate human LRP5 expression, contributing to the understanding of how the function of LRP5 is regulated during bone formation and eye development.
###end p 33
###begin title 34
Methods
###end title 34
###begin title 35
Cell culture
###end title 35
###begin p 36
###xml 494 496 494 496 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sub>
###xml 511 535 505 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila melanogaster </italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 36 41 <span type="species:ncbi:9606">human</span>
###xml 339 345 <span type="species:ncbi:9913">bovine</span>
###xml 511 534 <span type="species:ncbi:7227">Drosophila melanogaster</span>
###xml 698 704 <span type="species:ncbi:9913">bovine</span>
Human osteosarcoma cells (U2OS) and human embryonic kidney cells (HEK293) were purchased from the American Type Culture Collection (Manassas, VA). U2OS Cells were cultured in McCoy's 5A medium (Gibco, Invitrogen). HEK293 cells were maintained in Dulbecco's modified Eagle's medium (DMEM) (Gibco, Invitrogen). All media contained 10% fetal bovine serum (FBS), 100 units/ml penicillin, and 100 mg/ml streptomycin (Gibco BRL). Cells were incubated in a humidified incubator equilibrated with 5% CO2 at 37degreesC. Drosophila melanogaster Schneider cell line 2 (SL2; ATCC No. CRL-1963) was purchased from Invitogen (Carlsbad, CA) and maintained in Schneider's insect medium supplemented with 10% fetal bovine serum and 2 mM L-glutamine plus 100 units/ml penicillin and100 mg/ml streptomycin, and cultured at 25degreesC.
###end p 36
###begin title 37
RNA isolation and primer extension
###end title 37
###begin p 38
###xml 37 39 37 39 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sup>
###xml 340 345 340 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5 </italic>
###xml 571 576 571 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5 </italic>
###xml 638 640 634 636 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 669 671 665 667 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4 </sub>
###xml 698 700 694 696 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 722 724 718 720 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6 </sup>
###xml 1089 1094 1083 1088 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5 </italic>
###xml 334 339 <span type="species:ncbi:9606">human</span>
###xml 565 570 <span type="species:ncbi:9606">human</span>
###xml 851 854 <span type="species:ncbi:11866?0.5863095238095238|species:ncbi:12321?0.21726190476190477">AMV</span>
###xml 1083 1088 <span type="species:ncbi:9606">human</span>
When reaching 80% confluence in 75 cm2 flasks, U2OS cells were washed twice with ice-cold PBS and total RNA was isolated with the use of TRIzol reagents (Sigma-Aldrich, St. Louis, USA) according to the manufacturer's protocol. Any potential DNA contamination was removed by RNase-free DNase treatment. The transcription start site of human LRP5 gene was determined by primer extension using a primer extension system (Promega). An antisense primer (5'-GGCGGCGCTGCCTCCATGTTGTCCG-3'), corresponding to positions +107 to +131 (relative to transcription start site) of human LRP5 cDNA (GenBank accession No. ), was 5'end-labeled with [gamma -32P] ATP (3000 Ci/mmol) using T4 polynucleotide kinase. The 32P-labeled primer of 106 cpm was added to 50 mug of total RNA from U2OS cells in a final volume of 20 mul. The reverse transcription was performed with AMV reverse transcriptase according to the manufacturer's protocol. The reaction products were analyzed on 6% polyacrylamide/7 M urea gels alongside manual sequencing reaction of the plasmid DNA containing the 5'-flanking region of human LRP5 gene with the same end-labeled primer.
###end p 38
###begin title 39
Plasmids and Constructs
###end title 39
###begin p 40
###xml 72 77 72 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5 </italic>
###xml 134 139 134 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5 </italic>
###xml 200 205 200 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5 </italic>
###xml 364 365 364 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">1</xref>
###xml 795 796 795 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">1</xref>
###xml 66 71 <span type="species:ncbi:9606">human</span>
###xml 128 133 <span type="species:ncbi:9606">human</span>
###xml 194 199 <span type="species:ncbi:9606">human</span>
Utilizing the NCBI GenBank, we identified the genomic sequence of human LRP5 and found a BAC clone (PR11-149G19) containing the human LRP5 gene. We therefore amplified the proximal 5' region of human LRP5 (-2381 to +125 bp relative to transcription start site) by PCR using PR11-149G19 clone as the template. The primers (LRP5F and LRP5R) used are listed in Table 1. PCR product was cloned into pMD18-T vector (TaKaRa), and then subcloned into the firefly luciferase reporter vector pGL3-basic, a promoter-less luciferase expression plasmid (Promega, Madison, WI), creating pWT-2381. This construct was subsequently used as a template for the generation of a series of 5' unidirectional truncation mutants by PCR using assorted sense primers with a common antisense primer, LRP5R/HindIII (Table 1).
###end p 40
###begin p 41
The oligonucleotide sequence of primers used in PCR
###end p 41
###begin p 42
###xml 90 95 90 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5 </italic>
###xml 84 89 <span type="species:ncbi:9606">human</span>
Location: Nucleotide positions relative to the transcription start site (+1) of the human LRP5 gene.
###end p 42
###begin p 43
Restriction sites are indicated in bold. The nucleotides of specific mutagenesis are indicated in italic and bold.
###end p 43
###begin p 44
###xml 240 241 240 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">1</xref>
Mutant versions for specific binding sites were prepared by PCR-based mutagenesis from pWT-72, using the common reverse primer LRP5R/Hind III combining with the forward primers -72MT1/MluI, -72MT2/MluI and -72MT12/MluI, respectively (Table 1). The PCR conditions were as follows: the samples were denatured at 94degreesC for 4 min, and then 30 cycles were applied: 94degreesC for 40 s, 60degreesC for 40 s and 72degreesC for 50 s, the samples were further held at 72degreesC for 10 min. PCR products were digested with KpnI (or MluI) and HindIII enzymes, gel-purified, and ligated to the pGL3-basic vector. The sequences of all constructs were confirmed by restriction enzyme digestion and direct sequencing.
###end p 44
###begin p 45
###xml 8 19 8 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila </italic>
###xml 86 102 86 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 216 218 216 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 325 334 325 334 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CGCGGATCC</bold>
###xml 386 395 386 395 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCGCTCGAG</bold>
###xml 614 625 614 625 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila </italic>
###xml 86 102 <span type="species:ncbi:562">Escherichia coli</span>
pPac, a Drosophila actin 5C promoter-driven expression vector, pPac-gal containing an Escherichia coli-galactosidase, and pPacSp1 containing Sp1, were provided by Dr. G. Suske (Philipps-Universitat Marburg, Germany)[32]. The KLF15 coding cDNA was generated by reverse transcription-PCR from HEK293 total RNA with forward (5'-CGCGGATCCATGGTGGACCACTTACTTCCAGTGGACGAG-3') and reverse (5'- CCGCTCGAGTCAGTTCACGGAGCGCACGGAGCGGCTGCTC-3') primers. BamHI and XhoI restriction sites, respectively (bold), were introduced into the primers for subcloning. The amplicons were digested with BamHI and XhoI and inserted into the Drosophila pPac expression vector after excision of the Sp1 coding sequence from pPacSp1. Construct sequences were confirmed by DNA sequencing.
###end p 45
###begin title 46
Transient transfection and luciferase assay
###end title 46
###begin p 47
###xml 119 121 119 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 209 211 209 211 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4 </sup>
###xml 236 238 236 238 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4 </sup>
###xml 336 341 335 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5 </italic>
###xml 772 780 770 778 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla </italic>
Transient transfections were performed with the use of Lipofectamine 2000 reagent (Invitrogen) as previously described[33]. Briefly, U2OS and HEK293 cells were seeded into 48-well plates at a density of 5 x 104 cells per well and 4 x 104 cells per well, respectively, the day before transfection. For each well of cells, 0.4 mug of the LRP5 promoter constructs (deletion and site-directed mutants) were co-transfected with 0.02 mug of pRL-TK plasmid (Promega). The cells were cultured for 24 hours after transfection and then harvested. Luciferase activity was measured using the Dual-Luciferase Reporter Assay System (Promega). To normalize for transfection efficiency, the promoter activity of each construct was expressed as the ratio of firefly luciferase activity to Renilla luciferase activity. For each construct, more than three independent experiments with U2OS and HEK293 cells were performed in triplicate.
###end p 47
###begin p 48
###xml 132 134 132 134 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5 </sup>
For transient transfection of SL2 cells, one day prior to transfection, cells were plated into 24-well plates at a density of 5 x 105 cells/well. Cells were transfected with 0.5 mug of indicated reporter construct (pWT-72, pMT1-72 and pMT2-72) and 0.1 mug of pPacSp1 or pPac KLF15 expression vector or empty vector pPac0 together with pPac-beta-gal vector (internal reference encoding the beta-galactosidase gene). Twenty-four hours after transfection, the cells were harvested and luciferase activity was measured using Bright-Glo luciferase assay system (Promega) and beta-galactosidase activity was measured using Beta-Glo assay system (Promega). Luciferase activities were normalized to beta-galactosidase activity, reported as means of three independent experiments, and each performed in duplication.
###end p 48
###begin title 49
Chromatin immunoprecipitation assays (ChIP)
###end title 49
###begin p 50
###xml 883 891 883 891 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HSD17B5 </italic>
###xml 1046 1048 1046 1048 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
ChIP assays were performed using an EZ-ChIP assay kit (Upstate Biotechnologies, Millipore, MA) according to the manufacturer's instructions. Briefly, HEK293 cells were treated with formaldehyde and lysed with lysis buffer. The cell lysates were sonicated to generate 200-1000 bp DNA fragments, and cross-linked proteins were immunoprecipitated by incubation with antibodies against Sp1 (Santa Cruz, CA), KLF15 (Abcam, cambridge, UK), and IgG, respectively. A DNA sample from sonicated nuclear lysates that underwent reverse cross-link and phenol/chloroform extraction was used as positive control (input). A DNA sample immunoprecipitated by antibodies against IgG was used as negative control. Immunoprecipitated DNA was detected by PCR amplification using primer LRP5-ChIP-forward (5'-CCGCGGGGACCTGCGCCGCT-3') combining with primer LRP5R. As a positive control, specific primers of HSD17B5 promoter (5'-TTCTCCACAGACCATATAAG-3' and 5'-TTCCCTGTCACTTGTCTGACT-3') were designed to amplify the promoter region containing Sp1 the KLF15 binding sites [22]. PCR products were separated on 2% agarose gel and visualized by ethidium bromide staining.
###end p 50
###begin title 51
Statistical analysis
###end title 51
###begin p 52
The statistical significance of differences between experimental groups was calculated using the Student's test. Group differences were considered significant if P < 0.05.
###end p 52
###begin title 53
List of abbreviations
###end title 53
###begin p 54
###xml 161 166 <span type="species:ncbi:9606">human</span>
LRP5: low-density lipoprotein receptor related protein; Sp1: specificity protein 1; KLF15: Kruppel-like factor 15; ChIP: chromatin immunoprecipitation; HSD17B5: human 17-hydroxysteroid dehydrogenase type 5 gene.
###end p 54
###begin title 55
Authors' contributions
###end title 55
###begin p 56
JL performed luciferase reporter assay and ChIP analysis, and drafted the manuscript. YY and BJ participated in the primer extension and reporter assays. XZ and YZ assisted in RNA isolation and vector construction. YG contributed to the conception and the design of the study and the writing of the manuscript. All authors read and approved the final manuscript.
###end p 56
###begin title 57
Acknowledgements
###end title 57
###begin p 58
We thank Dr. G. Suske, Philipps-Universitat Marburg, Germany, for kindly providing pPac-gal and pPacSp1 constructs. We also express our thanks to Dr. Changshun Shao for critical reading of the manuscript and helpful advice. This work was supported by National Basic Research Program of China; grant number 2007CB512001, and National High-tech Research and Development Program of China; grant number: 2006AA02A406.
###end p 58
###begin article-title 59
Cloning of a novel member of the low-density lipoprotein receptor family
###end article-title 59
###begin article-title 60
Arrow encodes an LDL-receptor-related protein essential for Wingless signalling
###end article-title 60
###begin article-title 61
LDL-receptor-related proteins in Wnt signal transduction
###end article-title 61
###begin article-title 62
LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development
###end article-title 62
###begin article-title 63
###xml 116 120 <span type="species:ncbi:10090">mice</span>
Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor
###end article-title 63
###begin article-title 64
High bone density due to a mutation in LDL-receptor-related protein 5
###end article-title 64
###begin article-title 65
A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait
###end article-title 65
###begin article-title 66
Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density
###end article-title 66
###begin article-title 67
###xml 18 22 <span type="species:ncbi:10090">mice</span>
High bone mass in mice expressing a mutant LRP5 gene
###end article-title 67
###begin article-title 68
Association of a single-nucleotide polymorphism in low-density lipoprotein receptor-related protein 5 gene with bone mineral density
###end article-title 68
###begin article-title 69
Pathogenic mutations and polymorphisms in the lipoprotein receptor-related protein 5 reveal a new biological pathway for the control of bone mass
###end article-title 69
###begin article-title 70
###xml 65 70 <span type="species:ncbi:9606">women</span>
Contribution of the LRP5 gene to normal variation in peak BMD in women
###end article-title 70
###begin article-title 71
###xml 184 187 <span type="species:ncbi:9606">men</span>
Genetic variation at the low-density lipoprotein receptor-related protein 5 (LRP5) locus modulates Wnt signaling and the relationship of physical activity with bone mineral density in men
###end article-title 71
###begin article-title 72
Autosomal recessive familial exudative vitreoretinopathy is associated with mutations in LRP5
###end article-title 72
###begin article-title 73
Complexity of the genotype-phenotype correlation in familial exudative vitreoretinopathy with mutations in the LRP5 and/or FZD4 genes
###end article-title 73
###begin article-title 74
Mutations in LRP5 or FZD4 underlie the common familial exudative vitreoretinopathy locus on chromosome 11q
###end article-title 74
###begin article-title 75
Vascular development in the retina and inner ear: control by Norrin and Frizzled-4, a high-affinity ligand-receptor pair
###end article-title 75
###begin article-title 76
Functional candidate genes in age-related macular degeneration: significant association with VEGF, VLDLR, and LRP6
###end article-title 76
###begin article-title 77
Low-density lipoprotein receptor-related protein 5 (LRP5) is essential for normal cholesterol metabolism and glucose-induced insulin secretion
###end article-title 77
###begin article-title 78
###xml 85 89 <span type="species:ncbi:10090">mice</span>
Severe hypercholesterolemia, impaired fat tolerance, and advanced atherosclerosis in mice lacking both low density lipoprotein receptor-related protein 5 and apolipoprotein E
###end article-title 78
###begin article-title 79
Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum
###end article-title 79
###begin article-title 80
###xml 44 49 <span type="species:ncbi:9606">human</span>
###xml 180 185 <span type="species:ncbi:9606">women</span>
KLF15 Is a transcriptional regulator of the human 17beta-hydroxysteroid dehydrogenase type 5 gene. A potential link between regulation of testosterone production and fat stores in women
###end article-title 80
###begin article-title 81
Kruppel-like factors: three fingers in many pies
###end article-title 81
###begin article-title 82
Sp1- and Kruppel-like transcription factors
###end article-title 82
###begin article-title 83
Three conserved transcriptional repressor domains are a defining feature of the TIEG subfamily of Sp1-like zinc finger proteins
###end article-title 83
###begin article-title 84
The Kruppel-like factor KLF15 regulates the insulin-sensitive glucose transporter GLUT4
###end article-title 84
###begin article-title 85
Kruppel-like factor 15, a zinc-finger transcriptional regulator, represses the rhodopsin and interphotoreceptor retinoid-binding protein promoters
###end article-title 85
###begin article-title 86
Transcriptional regulation of the CLC-K1 promoter by myc-associated zinc finger protein and kidney-enriched Kruppel-like factor, a novel zinc finger repressor
###end article-title 86
###begin article-title 87
A Kruppel-like factor KLF15 contributes fasting-induced transcriptional activation of mitochondrial acetyl-CoA synthetase gene AceCS2
###end article-title 87
###begin article-title 88
The Sp-family of transcription factors
###end article-title 88
###begin article-title 89
A tale of three fingers: the family of mammalian Sp/XKLF transcription factors
###end article-title 89
###begin article-title 90
Sp1-mediated transcriptional activation is repressed by Sp3
###end article-title 90
###begin article-title 91
###xml 49 54 <span type="species:ncbi:9606">human</span>
Sp1 and CREB regulate basal transcription of the human SNF2L gene
###end article-title 91

